CA2582507A1 - Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers - Google Patents

Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers Download PDF

Info

Publication number
CA2582507A1
CA2582507A1 CA002582507A CA2582507A CA2582507A1 CA 2582507 A1 CA2582507 A1 CA 2582507A1 CA 002582507 A CA002582507 A CA 002582507A CA 2582507 A CA2582507 A CA 2582507A CA 2582507 A1 CA2582507 A1 CA 2582507A1
Authority
CA
Canada
Prior art keywords
methyl
butyl
tert
benzimidazol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002582507A
Other languages
English (en)
Inventor
Claire Milburn
Helene Desfosses
Daniel Page
Christopher Walpole
Zhong-Yong Wei
Hua Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2004/004124 external-priority patent/WO2005030732A1/fr
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CA2582507A1 publication Critical patent/CA2582507A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des composés de formule (I) ou des sels pharmaceutiquement acceptables desdits composés, formule dans laquelle R1, R2, R3, R4, R5, R6 et G sont tels que définis dans la spécification, ainsi que des sels et compositions pharmaceutiques contenant lesdits composés. Ces composés sont utiles en thérapie, notamment dans la gestion de la douleur.
CA002582507A 2004-09-24 2005-09-22 Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers Abandoned CA2582507A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBPCT/GB2004/004124 2004-09-24
PCT/GB2004/004124 WO2005030732A1 (fr) 2003-09-26 2004-09-24 Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ceux-ci
US64080404P 2004-12-30 2004-12-30
US60/640,804 2004-12-30
PCT/SE2005/001402 WO2006033630A1 (fr) 2004-09-24 2005-09-22 Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers

Publications (1)

Publication Number Publication Date
CA2582507A1 true CA2582507A1 (fr) 2006-03-30

Family

ID=36090309

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002582507A Abandoned CA2582507A1 (fr) 2004-09-24 2005-09-22 Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers

Country Status (5)

Country Link
EP (1) EP1797078A4 (fr)
JP (1) JP2008514592A (fr)
AU (1) AU2005287426A1 (fr)
CA (1) CA2582507A1 (fr)
WO (1) WO2006033630A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0302573D0 (sv) 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1797077B1 (fr) 2004-09-24 2012-02-15 AstraZeneca AB Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers
TW200745049A (en) 2006-03-23 2007-12-16 Astrazeneca Ab New crystalline forms
TW200808769A (en) 2006-04-18 2008-02-16 Astrazeneca Ab Therapeutic compounds
TW200808772A (en) * 2006-06-13 2008-02-16 Astrazeneca Ab Therapeutic compounds
US8236841B2 (en) * 2006-09-13 2012-08-07 Kyowa Hakko Kirin Co., Ltd. Fused heterocycle derivative
CN102325750A (zh) * 2008-12-18 2012-01-18 詹森药业有限公司 作为trpm8调节剂的磺酰胺
CA2747637A1 (fr) * 2008-12-18 2010-07-15 Janssen Pharmaceutica Nv Sulfamides au titre de modulateurs de trpm8
RU2418582C1 (ru) * 2010-04-08 2011-05-20 Аверин Константин Михайлович 1,3-диалкилбензимидазолия галогениды - средства для лечения рассеянного склероза

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101387D0 (sv) * 2001-04-20 2001-04-20 Astrazeneca Ab Novel compounds
SE0301701D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302573D0 (sv) * 2003-09-26 2003-09-26 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Also Published As

Publication number Publication date
JP2008514592A (ja) 2008-05-08
WO2006033630A1 (fr) 2006-03-30
EP1797078A1 (fr) 2007-06-20
AU2005287426A1 (en) 2006-03-30
EP1797078A4 (fr) 2009-04-01

Similar Documents

Publication Publication Date Title
US20090221657A1 (en) Compounds, Compositions Containing Them, Preparation Thereof and Uses Thereof I
US8633235B2 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2012530053A (ja) Ｔｒｐｍ８チャネルモジュレーターとして有用なベンゾイミダゾール誘導体
WO2006033628A1 (fr) Derives de benzimidazole, compositions les contenant et preparation et utilisation desdits derives
CA2582507A1 (fr) Derives de benzimidazole, compositions contenant ces derives, preparation et utilisations de ces derniers
US20070072853A1 (en) Benzimidazole derivatives compositions containing them, preparation thereof and uses thereof
US20080221178A1 (en) Benzimidazole Derivatives,Compositions Containing Them, Preparation Thereof and Uses Thereof
AU2005287427B2 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof I
TW200526592A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JPH02286677A (ja) テトラゾール置換ピペラジン化合物および該化合物を含有する医薬製剤
EP1794150A1 (fr) Derives de benzimidazole et leur utilisation comme ligands du recepteur cannabinoide
EP1797075A1 (fr) Derives de benzimidazole et leur utilisation en tant que ligands du recepteur cannabinoide
EP1797074A1 (fr) Composes, compositions les contenant, leur preparation et leur utilisation
KR20070054217A (ko) 화합물, 그를 함유하는 조성물, 그의 제조 방법 및 그의용도
CN101052639B (zh) 苯并咪唑衍生物、含有它们的组合物、其制备方法和其用途
HK1104823B (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
HK1089436B (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20090922